Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-09 5:22 pm Sale | 13G | MEI PHARMA INC MEIP | BlackRock Inc. BLK | 6,637,006 4.99% | -52,865 (-0.79%) | View |
| 2022-01-31 5:49 pm Sale | 13G | MEI PHARMA INC MEIP | BlackRock Inc. BLK | 6,689,871 5.9% | -297,805 (-4.26%) | View |
| 2021-02-16 3:44 pm Sale | 13G | MEI PHARMA INC MEIP | PERCEPTIVE ADVISORS LLC | 0 0% | -6,600,660 (Position Closed) | View |
| 2021-02-16 08:32 am Purchase | 13G | MEI PHARMA INC MEIP | UBS Oncology Impact Fund L.P. | 10,137,859 9% | 3,887,859 (+62.21%) | View |
| 2021-02-12 4:30 pm Sale | 13G | MEI PHARMA INC MEIP | Vivo Opportunity LLC | 3,300,330 2.8% | -7,372,117 (-69.08%) | View |
| 2021-02-11 5:29 pm Sale | 13G | MEI PHARMA INC MEIP | BIOTECHNOLOGY VALUE FUND L P | 5,589,315 4.9% | -1,297,110 (-18.84%) | View |
| 2021-02-02 3:13 pm Purchase | 13G | MEI PHARMA INC MEIP | BlackRock Inc. BLK | 6,987,676 6.2% | 6,987,676 (New Position) | View |
| 2020-02-14 4:19 pm Unchanged | 13G | MEI PHARMA INC MEIP | PERCEPTIVE ADVISORS LLC | 6,600,660 6.3% | 0 (Unchanged) | View |
| 2020-02-14 2:35 pm Purchase | 13G | MEI PHARMA INC MEIP | BIOTECHNOLOGY VALUE FUND L P | 6,886,425 6.4% | 2,367,564 (+52.39%) | View |
| 2020-02-13 5:05 pm Unchanged | 13G | MEI PHARMA INC MEIP | Helsinn Investment Fund S.A. SICAR | 2,616,431 2.5% | 0 (Unchanged) | View |
| 2020-02-13 4:30 pm Purchase | 13G | MEI PHARMA INC MEIP | Vivo Opportunity LLC | 10,672,447 9.99% | 3,419,698 (+47.15%) | View |
| 2020-02-05 2:11 pm Purchase | 13G | MEI PHARMA INC MEIP | UBS Oncology Impact Fund L.P. | 6,250,000 5.9% | 6,250,000 (New Position) | View |
| 2019-12-30 3:47 pm Purchase | 13D | MEI PHARMA INC MEIP | Growth Equity Opportunities V LLC | 9,963,216 9.8% | 2,937,575 (+41.81%) | View |
| 2019-09-25 5:09 pm Purchase | 13G | MEI PHARMA INC MEIP | PERCEPTIVE ADVISORS LLC | 6,600,660 8.7% | 2,200,220 (+50.00%) | View |